Category: CALEX® Cap

Do Not Forget About Pre-Analytics in Faecal Calprotectin Measurement!

BÜHLMANN fCAL® turbo and CALEX® Cap: Oyaert, M., Van den Bremt, S. et al. Do not forget about pre-analytics in faecal calprotectin measurement! Clinica Chimica Acta. 2017 Oct; 473:124-126. doi:10.1016/j.cca.2017.08.025. PMID: 28847684 . Highlights from this Publication This study found an optimal stability of fecal calprotectin when sampled with CALEX® extraction buffer and stored at 2-8 °C for 7 days. Furthermore, the
Continue Reading

CALEX® Cap Highlights

CALEX® Cap (K191718): FDA 510(k) cleared. For in vitro Diagnostic Use.  Health Canada License: 98839 CALEX® Cap Extraction Video Rapid, Clean, Consistent and Safe Sample Preparation The CALEX®Cap extraction device is designed to fulfill the requirements and need in the market for convenient and safe stool extraction. BÜHLMANN has strived to provide the best stool extraction option for calprotectin testing and
Continue Reading

New Health Canada Licences: Quantum Blue® Infliximab Assay, IBDoc®,CALEX® Cap

BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that three of its novel products, Quantum Blue® Infliximab Assay, IBDoc® and CALEX®Cap have received Medical Device Licences from Health Canada and are now commercially available in Canada. Quantum Blue® Infliximab® and CALEX® CAP devices were approved as Class 2 medical devices
Continue Reading